There were 28 cardiovascular deaths 19 deaths due to refractory HF and 9 sudden deaths during the follow-up, which corresponds to a mortality rate of 35.4%, with 19 deaths in the group with high TnT and 9 in the group with low TnT RR=2.40; 95%CI: 1.24-4.63, p=0.011.
Se produjeron 28 muertes cardiovasculares 19 muertes por IC refractaria y 9 muertes súbitas durante el seguimiento, que corresponde a una tasa de mortalidad de 35,4%, con 19 muertes en el grupo con TnTc elevada y 9 en el grupo con TnTc baja RR = 2,40; IC95% 1,24-4,63, p = 0,011.